© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#leukemia
How Does Leukemia Escape From Immunotherapy?
FDA Approves Venclexta for More Types of Leukemia
Leukemia 101
Jeff Neurman with his wife, Melissa

A Leukemia Diary: Jeff Neurman

Six years after his diagnosis with chronic lymphocytic leukemia, Jeff Neurman blogs and cohosts a podcast for men with cancer.

Blood Cancer Awareness Month

September was designated as National Blood Cancer Awareness Month in 2010 by United States Congress.

Early Palliative Care Reduces Anxiety and Depression in Acute Myeloid Leukemia Treatment

Starting palliative interventions at the onset of hospitalization for chemotherapy greatly improves quality of life.

FDA Approves Imbruvica Plus Rituxan for Chronic Lymphocytic Leukemia

Imbruvica plus Rituxan delayed disease progression when compared with a triple chemotherapy regimen.

Bookstore

Experimental Drug Prevents Heart Damage from Doxorubicin

“With BAX, we have a single target for blocking both types of cell death stemming from the use of doxorubicin."

Websites Worth Watching

Some helpful websites to to look up if you or one of your loved ones is living with cancer.

CAR-T for More Cancers

Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.
Red and white blood cells

Cancer Study May Help Researchers Create Usable Blood Stem Cells

The goal is to “make customizable stem cell products that could be adapted to any particular patient.”
Chimeric antigen receptor T-cell (CAR-T) therapy

CAR-T Therapies Show Promise for More Blood Cancers

Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.
Cancer treatment

Cancer Medications

Hot topics

Chronic Lymphocytic Leukemia
Acute Lymphocytic Leukemia

Targeted Combos Deal Double Blow Against Chronic Lymphocytic Leukemia

Imbruvica, Calquence and Venclexta demonstrate good results in combination regimens.
Catherine Wu, MD

Resistance to Targeted Leukemia Drug Lurks in Cells’ “Powerhouse”

In a recent study, Dana-Farber scientists and others uncovered a key part of why some patients eventually become resistant to Venclexta.
Red and white blood cells

FDA Approves New Treatment for Chronic Lymphocytic Leukemia

Calquence is the second therapy approved under a new program that lets companies simultaneously apply for approval in multiple countries.
David Lodge and Lara Stuart with their son, Quincy, now age 3, two years after his life-saving bone marrow stem cell transplant

How a Genetic Test Found a Life-Saving Therapy for an Infant’s Rare Cancer

Quincy’s treatment would take him and his family to the frontier of using precision medicine to find a drug to save the infant’s life.

Blood Cancer Awareness Month

September was designated as National Blood Cancer Awareness Month in 2010 by United States Congress.
Advertisement